This study aims to fill this knowledge gap by evaluating the association between Anti-TPO antibody levels and ovarian reserve markers across distinct clinical subgroups, while systematically accounting for the effects of BMI and PCOS. This evidence concerns the gene TPO and polycystic ovary syndrome.